Sign In
Buy MRNA
$47.44
-4.15 (-8.04%)
At Close: Jun 05, 2026
Is Moderna Stock A Buy As It Doubles Down On Its Cancer Vaccine Efforts?
02:34pm, Thursday, 29'th Jun 2023
Is Moderna stock a buy after unveiling new results for its Merck-partnered cancer vaccine? Is MRNA stock a buy today?
Moderna and 7 More Stocks That Can Beat Apple in Second Half
04:30am, Thursday, 29'th Jun 2023
Big Tech is having its best start to the year ever. But a different group of stocks may thrive in the second half.
Moderna, Inc. (MRNA) Is a Trending Stock: Facts to Know Before Betting on It
10:36am, Wednesday, 28'th Jun 2023
Moderna (MRNA) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
3 Pharma Stocks That Have Big Investors Running for the Exit
06:00am, Wednesday, 28'th Jun 2023
Pharmaceutical stocks are trailing the market this year. So far in 2023, the Dow Jones U.S. Select Pharmaceuticals Index is down 5.4% while all three major indices are positive on the year.
Moderna stock price forecast: UBS sees a 60% upside
01:55pm, Monday, 26'th Jun 2023
Moderna Inc (NASDAQ: MRNA) has been in a sharp downtrend since the start of this year but a UBS analyst says a full recovery is on the cards. Moderna shares could return to $191 Eliana Merle now recom
Moderna stock up after upgrade to Buy from Neutral
01:14pm, Monday, 26'th Jun 2023
Yahoo Finance anchor Rachelle Akuffo reports on Moderna stock up after the stock receives an upgrade to Buy from UBS. Yahoo Finance Live breaks down the company's stock movement.
Markets Little Changed Midday to Start the Last Trading Week of 2023's First Half
12:55pm, Monday, 26'th Jun 2023
U.S. equities were little changed at midday on Monday, June 26, 2023 heading into the last trading week of the month, quarter, and first half.
Moderna Stock Is a Buy. The Pipeline Is Underappreciated, Says Analyst.
10:39am, Monday, 26'th Jun 2023
UBS analyst Eliana Merle upgraded Moderna stock to Buy from Neutral, but trimmed the price target. The Covid and RSV businesses alone are worth $123 a share, she says.
Moderna Stock Upgrade Has Call Traders Moving In
10:19am, Monday, 26'th Jun 2023
UBS upgraded Moderna Inc (NASDAQ:MRNA) to "buy" from "neutral" this morning, but also lowered its price targe to $191 from $221.
UBS upgrades Moderna to buy while cutting price target
06:06am, Monday, 26'th Jun 2023
UBS upgraded its rating on vaccine maker Moderna MRNA, -1.64% to buy from neutral on valuation grounds, but cut its price target to $191 from $221. “We acknowledge the uncertainty around the commerc
Wall Street Says This Beaten-Down Stock May Climb Nearly 78%. Is That Too Optimistic?
05:30am, Saturday, 24'th Jun 2023
Moderna shares delivered enormous gains during the first year and a half of the pandemic. Since then, though, the stock has suffered as investors worry about declining revenues.
Moderna (MRNA) Seeks FDA Nod for Updated COVID-19 Vaccine
02:09pm, Friday, 23'rd Jun 2023
Moderna's (MRNA) updated COVID-19 vaccine is designed to target the XBB.1.5 sublineage. The company expects the vaccine to be available for the fall season, provided the FDA authorizes the same.
Moderna files for US FDA authorization of updated COVID vaccine
05:47pm, Thursday, 22'nd Jun 2023
Moderna said on Thursday it has completed the submission of a regulatory application to the U.S. Food and Drug Administration for its updated COVID-19 vaccine to target subvariant XBB.1.5.
Moderna files for FDA approval of updated Covid vaccine for fall
05:09pm, Thursday, 22'nd Jun 2023
Moderna said the submission is based on the FDA's recommendation that vaccine makers update their jabs to target omicron subvariant XBB.1.5.
Biotech ETFs in Focus on Covid Vaccines' Fall Rollout
03:37pm, Thursday, 22'nd Jun 2023
The FDA advised to Pfizer, Moderna and Novavax to manufacture single-strain jabs targeting the omicron subvariant XBB.1.5 should prove to be a victory for some biotech ETFs.
